New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
2022-01-01 Alberti, Andrea; Lorini, Luigi; Ravanelli, Marco; Perri, Francesco; Vinches, Marie; Rondi, Paolo; Romani, Chiara; Bossi, Paolo
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis
2013-01-01 Elting, Ls; Chang, Yc; Parelkar, P; Boers-Doets, Cb; Michelet, M; Hita, G; Rouleau, T; Cooksley, C; Halm, J; Vithala, M; Bossi, P; Escalante, C; Brennan, Mt
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy
2021-01-01 Tarricone, R.; Listorti, E.; Tozzi, V.; Torbica, A.; Banks, H.; Ghislandi, S.; Altini, M.; Annicchiarico, M.; Ardizzoni, A.; Bordon, P.; Bossi, P.; Cascinu, S.; Numico, G.; Puglisi, F.; Fasola, G.
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
2018-01-01 Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P. A.; Locati, L. D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P.
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders
2020-01-01 Antonuzzo, A.; Calabro, F.; Quaglino, P.; Roila, F.; Sebastiani, G. D.; Spina, F.; Pasqualetti, G.; Cortinovis, D.; Tagliaferri, E.; Peri, A.; Presotto, E. M.; Egidi, M. F.; Giacomelli, L.; Farroni, F.; Di Maio, M.; De Luca, E.; Danova, M.; Scotte, F.; Jordan, K.; Bossi, P.
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology
2015-01-01 Roila, F; Ripamonti, Ci; Antonuzzo, A; Bossi, P
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma
2022-01-01 Lechner, M.; Takahashi, Y.; Turri-Zanoni, M.; Liu, J.; Counsell, N.; Hermsen, M.; Kaur, R. P.; Zhao, T.; Ramanathan, M.; Schartinger, V. H.; Emanuel, O.; Helman, S.; Varghese, J.; Dudas, J.; Riechelmann, H.; Sprung, S.; Haybaeck, J.; Howard, D.; Engel, N. W.; Stewart, S.; Brooks, L.; Pickles, J. C.; Jacques, T. S.; Fenton, T. R.; Williams, L.; Vaz, F. M.; O'Flynn, P.; Stimpson, P.; Wang, S.; Hannan, S. A.; Unadkat, S.; Hughes, J.; Dwivedi, R.; Forde, C. T.; Randhawa, P.; Gane, S.; Joseph, J.; Andrews, P. J.; Royle, G.; Franchi, A.; Maragliano, R.; Battocchio, S.; Bewicke-Copley, H.; Pipinikas, C.; Webster, A.; Thirlwell, C.; Ho, D.; Teschendorff, A.; Zhu, T.; Steele, C. D.; Pillay, N.; Vanhaesebroeck, B.; Mohyeldin, A.; Fernandez-Miranda, J.; Park, K. W.; Le, Q. -T.; West, R. B.; Saade, R.; Manes, R. P.; Omay, S. B.; Vining, E. M.; Judson, B. L.; Yarbrough, W. G.; Sansovini, M.; Silvia, N.; Grassi, I.; Bongiovanni, A.; Capper, D.; Schuller, U.; Thavaraj, S.; Sandison, A.; Surda, P.; Hopkins, C.; Ferrari, M.; Mattavelli, D.; Rampinelli, V.; Facchetti, F.; Nicolai, P.; Bossi, P.; Henriquez, O. A.; Magliocca, K.; Solares, C. A.; Wise, S. K.; Llorente, J. L.; Patel, Z. M.; Nayak, J. V.; Hwang, P. H.; Lacy, P. D.; Woods, R.; O'Neill, J. P.; Jay, A.; Carnell, D.; Forster, M. D.; Ishii, M.; London, N. R.; Bell, D. M.; Gallia, G. L.; Castelnuovo, P.; Severi, S.; Lund, V. J.; Hanna, E. Y.
Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer
2020-01-01 Giralt, J.; Tao, Y.; Kortmann, R. -D.; Zasadny, X.; Contreras-Martinez, J.; Ceruse, P.; Arias de la Vega, F.; Lalla, R. V.; Ozsahin, E. M.; Pajkos, G.; Mazar, A.; Attali, P.; Bossi, P.; Vasseur, B.; Sonis, S.; Henke, M.; Bensadoun, R. -J.
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study
2021-01-01 Corino, V. D. A.; Bologna, M.; Calareso, G.; Licitra, L.; Ghi, M.; Rinaldi, G.; Caponigro, F.; Morelli, F.; Airoldi, M.; Allegrini, G.; Cassano, A.; Ferrari, D.; Mirabile, A.; Tosoni, A.; Galizia, D.; Merlano, M.; Sponghini, A.; Moretti, G.; Mainardi, L.; Bossi, P.
Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma
2013-01-01 Bossi, P; Perrone, F; Cortellazzi, B; Licitra, L; Dal Col, V; Laurini, E; Fermeglia, M; Prici, S
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
2017-01-01 Alfieri, S.; Granata, R.; Bergamini, C.; Resteghini, C.; Bossi, P.; Licitra, L. F.; Locati, L. D.
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis
2023-01-01 Petrelli, Fausto; Nardone, Massimiliano; Trevisan, Francesca; Carioli, Daniela; Falasca, Vincenzo; De Stefani, Agostina; Capriotti, Vincenzo; Gurizzan, Cristina; Lorini, Luigi; Berruti, Alfredo; Luciani, Andrea; Bossi, Paolo
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
2022-01-01 Mcdowell, L.; Bossi, P.
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
2015-01-01 De Cecco, L; Nicolau, M; Giannoccaro, M; Daidone, Mg; Bossi, P; Locati, L; Licitra, L; Canevari, S
Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II studies of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment-Trials in progress
2015-01-01 Pistillo, P; Bossi, P; Licitra, L
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients
2007-01-01 Bossi, P; Liberatoscioli, C; Bergamini, C; Locati, Ld; Fava, S; Rinaldi, G; Orlandi, E; Olmi, P; Tagliabue, E; Menard, S; Licitra, L
Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients
2012-01-01 Bossi, P; Filipazzi, P; Resteghini, C; Miceli, R; Orlandi, E; Locati, L; Fallai, C; Tana, S; Cova, A; Squarcina, P; Rodolfo, M; Bergamini, C; Granata, R; Mirabile, A; Rivoltini, L; Licitra, Lf
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review
2014-01-01 Orlandi, E; Takanen, S; Giandini, T; Iannacone, E; Fontanella, W; Locati, L; Carrara, M; Bossi, P; Bergamini, C; Granata, R; Tombolini, V; Ibba, T; Licitra, L; Pignoli, E; Fallai, C
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis
2023-01-01 Centonze, G.; Maisonneuve, P.; Prinzi, N.; Pusceddu, S.; Albarello, L.; Pisa, E.; Barberis, M.; Vanoli, A.; Spaggiari, P.; Bossi, P.; Cattaneo, L.; Sabella, G.; Solcia, E.; La Rosa, S.; Grillo, F.; Tagliabue, G.; Scarpa, A.; Papotti, M.; Volante, M.; Mangogna, A.; Del Gobbo, A.; Ferrero, S.; Rolli, L.; Roca, E.; Bercich, L.; Benvenuti, M.; Messerini, L.; Inzani, F.; Pruneri, G.; Busico, A.; Perrone, F.; Tamborini, E.; Pellegrinelli, A.; Kankava, K.; Berruti, A.; Pastorino, U.; Fazio, N.; Sessa, F.; Capella, C.; Rindi, G.; Milione, M.
The point of pain in head and neck cancer
2019-01-01 Bossi, P.; Giusti, R.; Tarsitano, A.; Airoldi, M.; De Sanctis, V.; Caspiani, O.; Alterio, D.; Tartaro, T.; Alfieri, S.; Siano, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma | 1-gen-2022 | Alberti, Andrea; Lorini, Luigi; Ravanelli, Marco; Perri, Francesco; Vinches, Marie; Rondi, Paolo; Romani, Chiara; Bossi, Paolo | |
| Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis | 1-gen-2013 | Elting, Ls; Chang, Yc; Parelkar, P; Boers-Doets, Cb; Michelet, M; Hita, G; Rouleau, T; Cooksley, C; Halm, J; Vithala, M; Bossi, P; Escalante, C; Brennan, Mt | |
| Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy | 1-gen-2021 | Tarricone, R.; Listorti, E.; Tozzi, V.; Torbica, A.; Banks, H.; Ghislandi, S.; Altini, M.; Annicchiarico, M.; Ardizzoni, A.; Bordon, P.; Bossi, P.; Cascinu, S.; Numico, G.; Puglisi, F.; Fasola, G. | |
| Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer | 1-gen-2018 | Cavalieri, S.; Perrone, F.; Miceli, R.; Ascierto, P. A.; Locati, L. D.; Bergamini, C.; Granata, R.; Alfieri, S.; Resteghini, C.; Galbiati, D.; Busico, A.; Paielli, N.; Patuzzo, R.; Maurichi, A.; Gallino, G.; Ruggeri, R.; Mariani, L.; Palla, M.; Licitra, L.; Bossi, P. | |
| Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders | 1-gen-2020 | Antonuzzo, A.; Calabro, F.; Quaglino, P.; Roila, F.; Sebastiani, G. D.; Spina, F.; Pasqualetti, G.; Cortinovis, D.; Tagliaferri, E.; Peri, A.; Presotto, E. M.; Egidi, M. F.; Giacomelli, L.; Farroni, F.; Di Maio, M.; De Luca, E.; Danova, M.; Scotte, F.; Jordan, K.; Bossi, P. | |
| NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology | 1-gen-2015 | Roila, F; Ripamonti, Ci; Antonuzzo, A; Bossi, P | |
| Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma | 1-gen-2022 | Lechner, M.; Takahashi, Y.; Turri-Zanoni, M.; Liu, J.; Counsell, N.; Hermsen, M.; Kaur, R. P.; Zhao, T.; Ramanathan, M.; Schartinger, V. H.; Emanuel, O.; Helman, S.; Varghese, J.; Dudas, J.; Riechelmann, H.; Sprung, S.; Haybaeck, J.; Howard, D.; Engel, N. W.; Stewart, S.; Brooks, L.; Pickles, J. C.; Jacques, T. S.; Fenton, T. R.; Williams, L.; Vaz, F. M.; O'Flynn, P.; Stimpson, P.; Wang, S.; Hannan, S. A.; Unadkat, S.; Hughes, J.; Dwivedi, R.; Forde, C. T.; Randhawa, P.; Gane, S.; Joseph, J.; Andrews, P. J.; Royle, G.; Franchi, A.; Maragliano, R.; Battocchio, S.; Bewicke-Copley, H.; Pipinikas, C.; Webster, A.; Thirlwell, C.; Ho, D.; Teschendorff, A.; Zhu, T.; Steele, C. D.; Pillay, N.; Vanhaesebroeck, B.; Mohyeldin, A.; Fernandez-Miranda, J.; Park, K. W.; Le, Q. -T.; West, R. B.; Saade, R.; Manes, R. P.; Omay, S. B.; Vining, E. M.; Judson, B. L.; Yarbrough, W. G.; Sansovini, M.; Silvia, N.; Grassi, I.; Bongiovanni, A.; Capper, D.; Schuller, U.; Thavaraj, S.; Sandison, A.; Surda, P.; Hopkins, C.; Ferrari, M.; Mattavelli, D.; Rampinelli, V.; Facchetti, F.; Nicolai, P.; Bossi, P.; Henriquez, O. A.; Magliocca, K.; Solares, C. A.; Wise, S. K.; Llorente, J. L.; Patel, Z. M.; Nayak, J. V.; Hwang, P. H.; Lacy, P. D.; Woods, R.; O'Neill, J. P.; Jay, A.; Carnell, D.; Forster, M. D.; Ishii, M.; London, N. R.; Bell, D. M.; Gallia, G. L.; Castelnuovo, P.; Severi, S.; Lund, V. J.; Hanna, E. Y. | |
| Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer | 1-gen-2020 | Giralt, J.; Tao, Y.; Kortmann, R. -D.; Zasadny, X.; Contreras-Martinez, J.; Ceruse, P.; Arias de la Vega, F.; Lalla, R. V.; Ozsahin, E. M.; Pajkos, G.; Mazar, A.; Attali, P.; Bossi, P.; Vasseur, B.; Sonis, S.; Henke, M.; Bensadoun, R. -J. | |
| A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study | 1-gen-2021 | Corino, V. D. A.; Bologna, M.; Calareso, G.; Licitra, L.; Ghi, M.; Rinaldi, G.; Caponigro, F.; Morelli, F.; Airoldi, M.; Allegrini, G.; Cassano, A.; Ferrari, D.; Mirabile, A.; Tosoni, A.; Galizia, D.; Merlano, M.; Sponghini, A.; Moretti, G.; Mainardi, L.; Bossi, P. | |
| Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma | 1-gen-2013 | Bossi, P; Perrone, F; Cortellazzi, B; Licitra, L; Dal Col, V; Laurini, E; Fermeglia, M; Prici, S | |
| Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? | 1-gen-2017 | Alfieri, S.; Granata, R.; Bergamini, C.; Resteghini, C.; Bossi, P.; Licitra, L. F.; Locati, L. D. | |
| Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis | 1-gen-2023 | Petrelli, Fausto; Nardone, Massimiliano; Trevisan, Francesca; Carioli, Daniela; Falasca, Vincenzo; De Stefani, Agostina; Capriotti, Vincenzo; Gurizzan, Cristina; Lorini, Luigi; Berruti, Alfredo; Luciani, Andrea; Bossi, Paolo | |
| The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer? | 1-gen-2022 | Mcdowell, L.; Bossi, P. | |
| Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data | 1-gen-2015 | De Cecco, L; Nicolau, M; Giannoccaro, M; Daidone, Mg; Bossi, P; Locati, L; Licitra, L; Canevari, S | |
| Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II studies of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment-Trials in progress | 1-gen-2015 | Pistillo, P; Bossi, P; Licitra, L | |
| Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients | 1-gen-2007 | Bossi, P; Liberatoscioli, C; Bergamini, C; Locati, Ld; Fava, S; Rinaldi, G; Orlandi, E; Olmi, P; Tagliabue, E; Menard, S; Licitra, L | |
| Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients | 1-gen-2012 | Bossi, P; Filipazzi, P; Resteghini, C; Miceli, R; Orlandi, E; Locati, L; Fallai, C; Tana, S; Cova, A; Squarcina, P; Rodolfo, M; Bergamini, C; Granata, R; Mirabile, A; Rivoltini, L; Licitra, Lf | |
| Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review | 1-gen-2014 | Orlandi, E; Takanen, S; Giandini, T; Iannacone, E; Fontanella, W; Locati, L; Carrara, M; Bossi, P; Bergamini, C; Granata, R; Tombolini, V; Ibba, T; Licitra, L; Pignoli, E; Fallai, C | |
| Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis | 1-gen-2023 | Centonze, G.; Maisonneuve, P.; Prinzi, N.; Pusceddu, S.; Albarello, L.; Pisa, E.; Barberis, M.; Vanoli, A.; Spaggiari, P.; Bossi, P.; Cattaneo, L.; Sabella, G.; Solcia, E.; La Rosa, S.; Grillo, F.; Tagliabue, G.; Scarpa, A.; Papotti, M.; Volante, M.; Mangogna, A.; Del Gobbo, A.; Ferrero, S.; Rolli, L.; Roca, E.; Bercich, L.; Benvenuti, M.; Messerini, L.; Inzani, F.; Pruneri, G.; Busico, A.; Perrone, F.; Tamborini, E.; Pellegrinelli, A.; Kankava, K.; Berruti, A.; Pastorino, U.; Fazio, N.; Sessa, F.; Capella, C.; Rindi, G.; Milione, M. | |
| The point of pain in head and neck cancer | 1-gen-2019 | Bossi, P.; Giusti, R.; Tarsitano, A.; Airoldi, M.; De Sanctis, V.; Caspiani, O.; Alterio, D.; Tartaro, T.; Alfieri, S.; Siano, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27918
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269653
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19972
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25665
- reserved1362
- open891